Protagonist Therapeutics IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 138.64 USD | 143,29 USD | 50,485 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 133,308 USD | 5 | 4 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 64.311.373 | 15 | 8,67 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Protagonist Therapeutics Inc
Mitarbeiter 131
Handelsplatz NASDAQ
Ticker Symbol PTGX
IPO Datum 2016-08-11
Adresse 7707 Gateway Boulevard, Newark, CA, United States, 94560
Webseite https://www.protagonist-inc.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Dinesh V. Patel Ph.D. | CEO, President, Secretary & Director |
| 2 | Mr. Asif Ali | Executive VP & CFO |
| 3 | Dr. Arturo M. Molina FACP, M.D., M.S. | Chief Medical Officer |
| 4 | Mr. Venkat Thalladi Ph.D. | EVP & Chief Technical Officer |
| 5 | Dr. Newman Yeilding M.D. | Executive VP, Chief Scientific Officer |
| 6 | Mr. Matthew M. Gosling J.D. | Executive VP and Chief Legal & Business Officer |
| 7 | Ms. Carena Spivey | Executive VP & Chief Human Resources Officer |
| 8 | Dr. Ashok Bhandari Ph.D. | EVP & Chief Discovery Officer |
| 9 | Mr. Carter J. King | Executive Vice President of Business Development |
| 10 | Ms. Abha Bommireddi | Executive VP & Chief of Staff |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Farallon Capital Management, L.L.C. | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 4 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 5 | RTW INVESTMENTS, LLC | 0,00% | 0,00 Mio. USD |
| 6 | Wellington Management Company LLP | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 9 | HHG PLC | 0,00% | 0,00 Mio. USD |
| 10 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 11 | Johnson & Johnson | 0,00% | 0,00 Mio. USD |
| 12 | Amvescap Plc. | 0,00% | 0,00 Mio. USD |
| 13 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 14 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |
| 15 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 16 | Woodline Partners LP | 0,00% | 0,00 Mio. USD |
| 17 | Bank of America Corp | 0,00% | 0,00 Mio. USD |
| 18 | Perceptive Advisors LLC | 0,00% | 0,00 Mio. USD |
| 19 | Jennison Associates LLC | 0,00% | 0,00 Mio. USD |
| 20 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |